Response to imatinib in villonodular pigmented synovitis (PVNS) resistant to nilotinib
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1186/2045-3329-3-8.pdf
Reference11 articles.
1. Mankin H, Trahan C, Hornicek F: Pigmented villonodular synovitis of joints. J Surg Oncol. 2011, 103: 386-389. 10.1002/jso.21835
2. Blay JY, El Sayadi H, Thiesse P: Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT). Ann Oncol. 2008, 19: 821-822.
3. Cassier PA, Gelderblom H, Stacchiotti S: Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis. Cancer. 2012, 118: 1649-1655. 10.1002/cncr.26409
4. West RB, Rubin BP, Miller MA: A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci USA. 2006, 103: 690-695. 10.1073/pnas.0507321103
5. Cupp JS, Miller MA, Montgomery KD: Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. Am J Surg Pathol. 2007, 31: 970-976. 10.1097/PAS.0b013e31802b86f8
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Keratin-Positive Giant Cell Tumor of Bone and Soft Tissue With HMGA2::NCOR2 Fusion in Children Under 10 With Response to Imatinib Therapy: A Case Series;JCO Precision Oncology;2024-06
2. Overview of Pharmacological Therapies for Diffuse Tenosynovial Giant Cell Tumor;Future Pharmacology;2023-12-01
3. Multimodal management of tenosynovial giant cell tumors (TGCT) in the landscape of new druggable targets;Journal of Surgical Oncology;2023-08-04
4. Novel CSF1R-positive tenosynovial giant cell tumor cell lines and their pexidartinib (PLX3397) and sotuletinib (BLZ945)-induced apoptosis;Human Cell;2022-12-02
5. Malignant giant cell tumors of the tendon sheath of the right hip: A case report;World Journal of Clinical Cases;2022-10-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3